FilingIndex
← The Wire
ENTXNasdaq

Entera Bio Ltd.

Biological Products, (No Diagnostic Substances) · L3 · CIK 1638097

Develops first-in-class oral tablet peptide therapies for chronic conditions

$61M
Market cap
$1.65
Last close
+1.2%
1D
+11.5%
5D
474K
Volume
Price · last 39 sessions+48.6%
May 4L $1.11 · H $1.65Jun 29
161
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end

Insider Activity

◆ Cluster Buy · 5 insiders

In the 90 days to Mar 9, 2026: 5 insiders bought $141K.

DateInsiderActionSharesPriceValue
Mar 9, 2026Germano Geno JDirectorBuy20,000$1.30$26K
Mar 5, 2026Ellis SeanDirectorBuy10,000$1.23$12K
Feb 12, 2026Rubin Steven DDirectorBuy5,000$1.49$7K
Feb 10, 2026Germano Geno JDirectorBuy20,000$1.49$30K
Feb 10, 2026Taitel HayaDirectorBuy7,500$1.48$11K
Feb 9, 2026Ellis SeanDirectorBuy18,000$1.24$22K
Feb 9, 2026Rubin Steven DDirectorBuy10,000$1.20$12K
Dec 29, 2025Toledano Miranda JayneChief Executive OfficerBuy11,000$1.81$20K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance